Back in July at ISMB we handed out t-shirts that had a picture of a nice looking cake piece and this text:
It’s a piece of cake! Just like your bioinformatics should be. Try a piece of delicious cakeformatics from the cake loving company, CLC bio
The overall idea is: Who doesn’t like cake in some form or another? Almost no one. So basically ‘cake’ makes you think of something nice. And that’s the same thing our users are saying about our software: Instead of bioinformatics having to be a headache with Linux computers and mile-long command-line scripts, it’s instead multiple powerful analyses through an intuitive graphical user interface. It’s nice.
In essence: Cakeformatics is basically just bioinformatics the delicious way. Just like we like it. Enjoy!
Scientist, Jeremy Lambert, from RainDance elaborates on how their microdroplet technology, high-throughput sequencing, and CLC bio’s bioinformatics tools can be used in resequencing projects to effectively speed up the process of analyzing complex diseases. In this video examplified by a publication on X-Linked mental retardation from the Max-Planck Institute.
A lot of very interesting research is going on everywhere around the world, and it’s hard to keep up with all the exciting things going on, so here’s a glimpse of some of it.
Recently we stopped by our friends at the Oklahoma Medical Research Foundation, Patrick Gaffney, MD, and Graham Wiley, PhD, to learn more about their sequence capture approach to identifying novel genes that are linked to Lupus erythematosus. Check out the video below to learn more!
Here’s a brilliant piece on the sequencing technologies in 2010, written by Dan Koboldt over at his MassGenomics blog.
Something had been bothering me about the sequencing-company presentations this year, and I finally realized what it was. During AGBT 2009, every player was gunning to take over the world. This year it seems like every sequencing platform has a niche in mind.
Today Pacific Biosciences announced the initial members of their partner program, and CLC bio is included as the only high-throughput sequencing data analysis software provider.
We have thought carefully about what it takes to successfully introduce a new generation of technology to the marketplace, and putting in place an entire ecosystem of complementary solutions has been one of our strategies from the beginning, states Hugh Martin, Chairman and Chief Executive Officer of Pacific Biosciences.
From CLC bio’s start 5 years ago, it has been a core strategy for us to be an independent, cross-platform software provider, whether it relates to operating systems or high-throughput sequencing instruments. We’re currently supporting all the second generation sequencing instruments from Illumina, Applied Biosystems, Roche 454, as well as Helicos. We’re continuing that strategy with the 3rd generation sequencers starting to come out this year.
